Top Markets
Coin of the day
Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE
Rang in aandelen #632
Kenvue Inc. operates as a consumer health company worldwide. The company... Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Aandeelprijs
$17.52
Marktkapitalisatie
$33.58B
Verandering (1 dag)
-0.28%
Verandering (1 jaar)
-26.08%
Land
US
Handel Kenvue Inc. (KVUE)
Winst voor Kenvue Inc. (KVUE)
Winst in Dec 2025 TTM: $2.00B
Volgens de meest recente financiële verslagen van Kenvue Inc. bedraagt de huidige winst van het bedrijf $2.00B. In 2023 behaalde het bedrijf een winst van $2.19B, een daling ten opzichte van de winst van 2022, die $2.64B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Kenvue Inc. van 2019 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $2.00B 41.27%
2024 $1.42B -35.39%
2023 $2.19B -16.95%
2022 $2.64B -9.85%
2021 $2.93B -387.89%
2020 $-1.02B -147.92%
2019 $2.12B 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$20.64B 932.37%
US
$9.97B 398.69%
FR
$9.80B 390.08%
GB
$3.06B 53.03%
US
$1.46B -26.88%
IN